The development of new weight loss drugs is one way that patient access can be ensured in the future.
- Research Lead/Advanced Clinical Practitioner/Senior Research Fellow, University of Bradford
Alongside COVID and the flu, cases of norovirus and RSV are already surging this year.
The weight loss drug is even more effective than Wegovy.
Drugs for menopause, ADHD and type 2 diabetes were all in short supply this year.
Ongoing shortages of the drug have been reported in the UK, Australi and Ireland.
A combination of high demand and poor stock planning may explain current problems.
Many common medications – including those prescribed for menopause, dementia, and depression – are currently seeing shortages worldwide.
Current supply shortages may also be a problem for people in palliative care or receiving cancer treatment.
Contact Zoe for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Location: Leeds
- Website
- X (formerly Twitter): @Zoeed1
- Article Feed
- ORCID
- Joined
